Citadel Advisors LLC 13D/13G Filings for Lyra Therapeutics, Inc. (LYRA)

Citadel Advisors LLC 13D and 13G filings for Lyra Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-14
6:22 pm
Sale		 2024-12-31 13G Lyra Therapeutics, Inc.
LYRA		 Citadel Advisors LLC 422
0.000%		 -85,317decrease
(-99.51%)		 Filing
2024-02-14
6:18 pm
Purchase		 2023-12-31 13G Lyra Therapeutics, Inc.
LYRA		 Citadel Advisors LLC 85,739
7.900%		 27,808increase
(+48.00%)		 Filing
2023-06-12
5:23 pm
Purchase		 2023-05-31 13G Lyra Therapeutics, Inc.
LYRA		 Citadel Advisors LLC 57,931
5.900%		 57,931increase
(New Position)		 Filing